This report aims to provide a comprehensive presentation of the global market for Infectious Diseases In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases In Vitro Diagnostics. This report contains market size and forecasts of Infectious Diseases In Vitro Diagnostics in global, including the following market information:
Global Infectious Diseases In Vitro Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Infectious Diseases In Vitro Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
MRSA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Infectious Diseases In Vitro Diagnostics include BD, Abbott, Alere, Quidel, F. Hoffmann-La Roche, Orasure Technologies, Cepheid, Hologic and Qiagen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Diseases In Vitro Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Diseases In Vitro Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases In Vitro Diagnostics Market Segment Percentages, by Type, 2022 (%)
MRSA
Streptococcus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis C
Others
Global Infectious Diseases In Vitro Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases In Vitro Diagnostics Market Segment Percentages, by Application, 2022 (%)
Immunochemistry
Molecular Diagnostics
Microbiology
Others
Global Infectious Diseases In Vitro Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Infectious Diseases In Vitro Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Diseases In Vitro Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Infectious Diseases In Vitro Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Diseases In Vitro Diagnostics, market overview.
Chapter 2: Global Infectious Diseases In Vitro Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Infectious Diseases In Vitro Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Diseases In Vitro Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Infectious Diseases In Vitro Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Diseases In Vitro Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Diseases In Vitro Diagnostics Overall Market Size
2.1 Global Infectious Diseases In Vitro Diagnostics Market Size: 2022 VS 2029
2.2 Global Infectious Diseases In Vitro Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Diseases In Vitro Diagnostics Players in Global Market
3.2 Top Global Infectious Diseases In Vitro Diagnostics Companies Ranked by Revenue
3.3 Global Infectious Diseases In Vitro Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Diseases In Vitro Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Infectious Diseases In Vitro Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Diseases In Vitro Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Infectious Diseases In Vitro Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Diseases In Vitro Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Infectious Diseases In Vitro Diagnostics Market Size Markets, 2022 & 2029
4.1.2 MRSA
4.1.3 Streptococcus
4.1.4 TB and Drug-resistant TB
4.1.5 Gastro-intestinal Panel Testing
4.1.6 HIV
4.1.7 Hepatitis C
4.1.8 Others
4.2 By Type - Global Infectious Diseases In Vitro Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Infectious Diseases In Vitro Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Infectious Diseases In Vitro Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Diseases In Vitro Diagnostics Market Size, 2022 & 2029
5.1.2 Immunochemistry
5.1.3 Molecular Diagnostics
5.1.4 Microbiology
5.1.5 Others
5.2 By Application - Global Infectious Diseases In Vitro Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Infectious Diseases In Vitro Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Infectious Diseases In Vitro Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Infectious Diseases In Vitro Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Infectious Diseases In Vitro Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Infectious Diseases In Vitro Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Infectious Diseases In Vitro Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Infectious Diseases In Vitro Diagnostics Revenue, 2018-2029
6.3.2 US Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.3.3 Canada Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.3.4 Mexico Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Infectious Diseases In Vitro Diagnostics Revenue, 2018-2029
6.4.2 Germany Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.4.3 France Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.4.4 U.K. Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.4.5 Italy Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.4.6 Russia Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.4.8 Benelux Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Infectious Diseases In Vitro Diagnostics Revenue, 2018-2029
6.5.2 China Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.5.3 Japan Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.5.4 South Korea Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.5.6 India Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Infectious Diseases In Vitro Diagnostics Revenue, 2018-2029
6.6.2 Brazil Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.6.3 Argentina Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue, 2018-2029
6.7.2 Turkey Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.7.3 Israel Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
6.7.5 UAE Infectious Diseases In Vitro Diagnostics Market Size, 2018-2029
7 Infectious Diseases In Vitro Diagnostics Companies Profiles
7.1 BD
7.1.1 BD Company Summary
7.1.2 BD Business Overview
7.1.3 BD Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.1.4 BD Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.1.5 BD Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.2.4 Abbott Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Alere
7.3.1 Alere Company Summary
7.3.2 Alere Business Overview
7.3.3 Alere Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.3.4 Alere Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Alere Key News & Latest Developments
7.4 Quidel
7.4.1 Quidel Company Summary
7.4.2 Quidel Business Overview
7.4.3 Quidel Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.4.4 Quidel Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Quidel Key News & Latest Developments
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Summary
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.5.4 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Key News & Latest Developments
7.6 Orasure Technologies
7.6.1 Orasure Technologies Company Summary
7.6.2 Orasure Technologies Business Overview
7.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.6.4 Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Orasure Technologies Key News & Latest Developments
7.7 Cepheid
7.7.1 Cepheid Company Summary
7.7.2 Cepheid Business Overview
7.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.7.4 Cepheid Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Cepheid Key News & Latest Developments
7.8 Hologic
7.8.1 Hologic Company Summary
7.8.2 Hologic Business Overview
7.8.3 Hologic Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.8.4 Hologic Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Hologic Key News & Latest Developments
7.9 Qiagen
7.9.1 Qiagen Company Summary
7.9.2 Qiagen Business Overview
7.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.9.4 Qiagen Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Qiagen Key News & Latest Developments
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Company Summary
7.10.2 Bio-Rad Laboratories Business Overview
7.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.10.4 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Bio-Rad Laboratories Key News & Latest Developments
7.11 Siemens Healthcare
7.11.1 Siemens Healthcare Company Summary
7.11.2 Siemens Healthcare Business Overview
7.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Major Product Offerings
7.11.4 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Siemens Healthcare Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Infectious Diseases In Vitro Diagnostics Market Opportunities & Trends in Global Market
Table 2. Infectious Diseases In Vitro Diagnostics Market Drivers in Global Market
Table 3. Infectious Diseases In Vitro Diagnostics Market Restraints in Global Market
Table 4. Key Players of Infectious Diseases In Vitro Diagnostics in Global Market
Table 5. Top Infectious Diseases In Vitro Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Infectious Diseases In Vitro Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Infectious Diseases In Vitro Diagnostics Product Type
Table 9. List of Global Tier 1 Infectious Diseases In Vitro Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Diseases In Vitro Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Infectious Diseases In Vitro Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Infectious Diseases In Vitro Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Infectious Diseases In Vitro Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Infectious Diseases In Vitro Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. BD Company Summary
Table 31. BD Infectious Diseases In Vitro Diagnostics Product Offerings
Table 32. BD Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. BD Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Infectious Diseases In Vitro Diagnostics Product Offerings
Table 36. Abbott Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. Alere Company Summary
Table 39. Alere Infectious Diseases In Vitro Diagnostics Product Offerings
Table 40. Alere Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Alere Key News & Latest Developments
Table 42. Quidel Company Summary
Table 43. Quidel Infectious Diseases In Vitro Diagnostics Product Offerings
Table 44. Quidel Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Quidel Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Company Summary
Table 47. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product Offerings
Table 48. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffmann-La Roche Key News & Latest Developments
Table 50. Orasure Technologies Company Summary
Table 51. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product Offerings
Table 52. Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Orasure Technologies Key News & Latest Developments
Table 54. Cepheid Company Summary
Table 55. Cepheid Infectious Diseases In Vitro Diagnostics Product Offerings
Table 56. Cepheid Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Cepheid Key News & Latest Developments
Table 58. Hologic Company Summary
Table 59. Hologic Infectious Diseases In Vitro Diagnostics Product Offerings
Table 60. Hologic Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Hologic Key News & Latest Developments
Table 62. Qiagen Company Summary
Table 63. Qiagen Infectious Diseases In Vitro Diagnostics Product Offerings
Table 64. Qiagen Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Qiagen Key News & Latest Developments
Table 66. Bio-Rad Laboratories Company Summary
Table 67. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product Offerings
Table 68. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Bio-Rad Laboratories Key News & Latest Developments
Table 70. Siemens Healthcare Company Summary
Table 71. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product Offerings
Table 72. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Siemens Healthcare Key News & Latest Developments
List of Figures
Figure 1. Infectious Diseases In Vitro Diagnostics Segment by Type in 2022
Figure 2. Infectious Diseases In Vitro Diagnostics Segment by Application in 2022
Figure 3. Global Infectious Diseases In Vitro Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Infectious Diseases In Vitro Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Infectious Diseases In Vitro Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2022
Figure 8. By Type - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Infectious Diseases In Vitro Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. BD Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Alere Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Quidel Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cepheid Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hologic Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Qiagen Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
